ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,05
-0,09%
Bitcoin
63 862,70
-0,21%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Oragenics Inc (OGEN)

  7. Oragenics Inc (OGEN) Actualités

OGEN

Oragenics (OGEN)

Oragenics Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:OGEN
DateHeureSourceTitreSymboleSociété
19/04/202423h50Business WireOragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsAMEX:OGENOragenics Inc
01/04/202415h05Business WireOragenics, Inc. Files 10K and Provides Company UpdateAMEX:OGENOragenics Inc
18/03/202412h00Business WireOragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating ConcussionAMEX:OGENOragenics Inc
06/03/202422h24Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:OGENOragenics Inc
05/03/202413h45Business WireOragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat ConcussionAMEX:OGENOragenics Inc
01/03/202422h04Business WireOragenics Announces Closing of Public OfferingAMEX:OGENOragenics Inc
29/02/202422h41Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:OGENOragenics Inc
28/02/202415h03Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
28/02/202403h25Business WireOragenics Announces Pricing of Public OfferingAMEX:OGENOragenics Inc
27/02/202423h09Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:OGENOragenics Inc
27/02/202422h33Business WireOragenics Announces Proposed Public OfferingAMEX:OGENOragenics Inc
13/02/202402h06Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipAMEX:OGENOragenics Inc
12/02/202422h41Business WireOragenics, Inc. Announces Leadership TransitionAMEX:OGENOragenics Inc
07/02/202414h00Business WireOragenics, Inc. Announces Expiration of Its Investment Banking Engagement AgreementAMEX:OGENOragenics Inc
05/02/202414h00Business WireOragenics, Inc. Preparing for Phase II Clinical Trials to Treat ConcussionAMEX:OGENOragenics Inc
23/01/202423h34Business WireOragenics Announces Termination of At-The-Market Offering ProgramAMEX:OGENOragenics Inc
22/01/202423h30Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesAMEX:OGENOragenics Inc
10/01/202422h37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:OGENOragenics Inc
02/01/202423h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:OGENOragenics Inc
02/01/202422h40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:OGENOragenics Inc
02/01/202413h30Business WireOragenics Completes Acquisition of Odyssey Health’s Neurological AssetsAMEX:OGENOragenics Inc
30/11/202323h50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:OGENOragenics Inc
16/11/202320h37Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:OGENOragenics Inc
02/11/202312h00Business WireOragenics Issues Update to ShareholdersAMEX:OGENOragenics Inc
30/10/202321h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:OGENOragenics Inc
18/10/202314h30Business WireOragenics Announces Appointment of Bruce Cassidy and John Gandolfo to Board of DirectorsAMEX:OGENOragenics Inc
05/10/202312h30Business WireOragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug CandidateAMEX:OGENOragenics Inc
29/09/202322h00Business WireOragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy AssetsAMEX:OGENOragenics Inc
11/08/202322h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:OGENOragenics Inc
07/08/202314h30Business WireOragenics, Inc. Announces Private PlacementAMEX:OGENOragenics Inc
 Showing the most relevant articles for your search:AMEX:OGEN

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
LR
Legrand
EU
CAP
Capgemini
EU
VK
Vallourec
EU
RI
Pernod Ricard
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
FTSE
UKX
FTSE 100
EU
BN
Danone
EU
VIV
Vivendi
EU
CS
Axa
EU
SGO
Cie de SaintGobain
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés